| Literature DB >> 32039045 |
Shui-Zhen Wu1, Hai-Xia Wei1, Dan Jiang1, Sheng-Min Li1, Wei-Hao Zou1, Hong-Juan Peng1.
Abstract
Toxoplasma gondii are obligate intracellular protoza, and due to their small genome and limited encoded proteins, they have to exploit host factors for entry, replication, and dissemination. Such host factors can be defined as host dependency factors (HDFs). Though HDFs are inessential for cell viability, they are critical for pathogen infection, and potential ideal targets for therapeutic intervention. However, information about these HDFs required by T. gondii infection is highly deficient. In this study, the genes of human foreskin fibroblast (HFF) cells were comprehensively edited using the lentiviral CRISPR-Cas9-sgRNA library, and then the lentivirus-treated cells were infected with T. gondii at multiplication of infection 1 (MOI = 1) for 10 days to identify HDFs essential for T. gondii infection. The survival cells were harvested and sent for sgRNA sequencing. The sgRNA sequence matched genes or miRNAs were potential HDFs. Some cells in the lentivirus-treated group could survive longer than those in the untreated control group after T. gondii infection. From a pool of 19,050 human genes and 1,864 human pri-miRNAs, 1,193 potential HDFs were identified, including 1,183 genes and 10 pri-miRNAs (corresponding with 17 mature miRNAs). Among them, seven genes and five mature miRNAs were validated with siRNAs, miRNA inhibitors, and mimics, respectively. Bioinformatics analysis revealed that, among the 1,183 genes, 53 potential HDFs were associated with regulation of host actin cytoskeleton and 23 potential HDFs coded immune negative regulators. This result indicated that actin dynamics were indispensable for T. gondii infection, and some host immune negative regulators may be involved in disarming host defenses. Our findings contribute to the current limited knowledge about host factors required by T. gondii infection and provide us with new targets for medication therapy and vaccine exploitation.Entities:
Keywords: CRISPR-Cas9; Toxoplasma gondii; actin cytoskeleton; genome-wide; host dependency factors; immune regulation
Year: 2020 PMID: 32039045 PMCID: PMC6987080 DOI: 10.3389/fcimb.2019.00460
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Screening of host dependency factors required by Toxoplasma gondii infection with CRISPR/CAS9-sgRNA library. (A) Screening flowchart. Human foreskin fibroblast (HFF) cells were transduced with lentiviruses at multiplicity of infection 1 (MOI = 1). Cells were subsequently selected using puromycin for 5 days. Transduced cells were infected with T. gondii (MOI = 1) for 10 days. Finally, the transduced cells that survived T. gondii infection were harvested, and the genomic DNA was extracted and subjected to high-throughput sequencing. (B) Venn diagram depicting the number of screened targets from independent biological triplicates: first replicate (red), second replicate (lime), third replicate (blue), and overlapped targets (middle).
Figure 2Validation of seven selected T. gondii host dependency factors (HDFs). (A) Among the HDFs, seven genes (CBLB, USP17L24, USP19, HDAC7, ULK1, PIM1, and ENPP5) were selected for siRNA gene knockdown assay on Hela cells. Three siRNAs were designed for each gene, and siRNAs with the highest knockdown efficiency were chosen for the further experiments. (B) When specific genes were knocked down with selected siRNA for 24 h, T. gondii was used to infect cells at MOI = 1 for 36 h. Proliferation of T. gondii was significantly inhibited in siRNA treated groups compared with mock and negative control siRNA treated groups. (C,D) FAM-tagged control miRNA inhibitor and mimic transfected Hela cells showed the transfection rate. (E,F) Compared with mock and negative control siRNA treated groups, multiplication of T. gondii was significantly suppressed in specific miRNA inhibitor treated group, but not significantly changed in mimic treated group. (G) Viability of Hela cells in siRNA, inhibitor, and mimic treated groups was not significantly changed. * p < 0.05, ** p < 0.01, *** p < 0.005.
Figure 3The top 10 enriched biological processes for host dependency genes and predicted target genes of host dependency miRNAs identified by Gene Ontology (GO) analysis. (A) Host dependency genes were significantly over-represented in the biological processes of actin filament organization, negative regulation processes, and regulation of apoptotic processes. (B) Host dependency miRNA predicted target genes were involved in a variety of positive regulation process, such as “positive regulation of transcription, DNA-templated” and “positive regulation of gene expression.” Stacked bar chart indicates the number of proteins overlapped with the database, and connected orange points represent the logarithm of p-values.
Figure 4The top 10 enriched pathways for host dependency genes. Stacked bar chart indicates the number of proteins overlapped with the database, and connected orange points represent p-values.
Figure 5Protein–protein interaction (PPI) network of host dependency genes. Among the 1,183 proteins, 428 (36.12%) of host dependency genes were enriched in a large PPI network, with 1,136 edges. Seven PPI clusters were evident in the network. The biggest one is a cluster of E3 ubiquitin-protein ligases containing 25 proteins (in green), including TRIM63, UBE3D, HECTD1, ARIH2, ZNF645, and CBLB, was observed as one of the main hubs. The second one is a cluster of 25 olfactory receptor proteins (in red) with RTP1 in the center. A cluster of 12 USP proteins (in medium slate blue) was also found protruding. Detailed information on these seven PPI clusters is shown in Table S6.
The 23 screened host dependency genes of T. gondii contributing to immune tolerance.
| ADAR | T cell self-tolerance; a feedback suppressor of innate immunity | O'Connell et al., |
| Bcl10 | B cell tolerance | Yu et al., |
| Bcl2 | B-cell tolerance | Tsubata, |
| C1qa | Facilitate the induction of intranasal tolerance | Baruah et al., |
| CBLB | T- cell dysfunction, and negatively regulate innate immunity | Liu et al., |
| CD84 | B cell tolerance | Wong et al., |
| CDC42 | Suppress Th17 aberrant differentiation/pathogenicity and promote of Treg differentiation/stability/function | Kalim et al., |
| CEACAM1 | T-cell inhibition; deletion of CEACAM1 in mice causes exacerbation of inflammation and hyperactivation of myeloid cells and lymphocytes | Huang et al., |
| DOK2 | Involved in an intrinsic negative feedback loop downstream of NK-cell-activating receptors and early T cell receptor signal | Dong et al., |
| Fas | Maintenance of immune tolerance by regulating T cell and B cell immunity | Yamada et al., |
| HDAC7 | T cell self-tolerance | Verdin et al., |
| IL4I1 | Inhibits T-cell proliferation and production of IFN-γ and inflammatory cytokines | Marquet et al., |
| LRP6 | Decreased effector T cell differentiation and increased regulatory T cell differentiation | Hong et al., |
| NFIL3 | T-cell dysfunction | Zhu et al., |
| NRP1 | A higher proportion of Nrp1−/− Regulatory T cells produce IFNγ than (Nrp1+/+) Tregs. | Overacre-Delgoffe et al., |
| PIM1 | Facilitates promotion of viral infectivity by counteracting the host antiviral system | Miyakawa et al., |
| PRKCI | In human ovarian cancers, high PRKCI expression correlates with high expression of TNFα and YAP1 and low infiltration of cytotoxic T cells | Sarkar et al., |
| SEMA3A | Suppressing the over-activity of both T and B cell autoimmunity | Vadasz and Toubi, |
| Sh2b3 | Negatively regulates cytokine signaling in lymphohematopoiesis | Mori et al., |
| SIRT2 | Decreased LPS and poly (I:C) induced IL-6, TNF-α and MCP-1 expressions | Qin et al., |
| SMAD3 | Cytokine suppression | Yoshimura and Muto, |
| SUMO4 | Negatively regulates NF-kB transcriptional pathway | Park, |
| TIGIT | Suppresses T cell activation; decreases IFN-γ production. | Yu et al., |